Dawn Waldorf

Dawn Waldorf is a seasoned professional in the pharmaceutical industry, currently serving as Key Account Manager at CTI BioPharma since October 2021. Waldorf has extensive experience in hematology oncology, having worked as a Hematology Oncology Consultant at Celgene from September 2013 to October 2021 and as a Senior Hematology Consultant at Bristol Myers Squibb during the same period. Prior roles include Territory Manager positions at Prostrakan Inc. and Bristol-Myers Squibb, with notable achievements in promoting Sprycel and Erbitux. Earlier experience includes a District Manager role at Schering-Plough Research Institute, specializing in hyperlipidemia and allergy, and another District Manager position at ADP, where Waldorf earned accolades as a President Club winner. Waldorf holds a BA in Communications from the University of Central Florida, completed in 1995.